These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alterations in aldosterone secretion and metabolism in low renin hypertension. Griffing GT; Wilson TE; Melby JC J Clin Endocrinol Metab; 1990 Dec; 71(6):1454-60. PubMed ID: 2229301 [TBL] [Abstract][Full Text] [Related]
4. Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by enalapril (MK-421): a new angiotensin-converting enzyme inhibitor. Griffing GT; Sindler BH; Aurecchia SA; Melby JC Metabolism; 1983 Jul; 32(7):711-6. PubMed ID: 6306388 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade. Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790 [TBL] [Abstract][Full Text] [Related]
6. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism. Griffing GT; Melby JC Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies: enalapril versus hydrochlorothiazide as first-step therapy for the treatment of primary hypertension. Bauer JH; Jones LB Am J Kidney Dis; 1984 Jul; 4(1):55-62. PubMed ID: 6331157 [TBL] [Abstract][Full Text] [Related]
8. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. Brunner DB; Desponds G; Biollaz J; Keller I; Ferber F; Gavras H; Brunner HR; Schelling JL Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131 [TBL] [Abstract][Full Text] [Related]
9. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. Tylicki L; Rutkowski P; Renke M; LarczyĆski W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812 [TBL] [Abstract][Full Text] [Related]
10. [Effect of CYP11B2 gene -344T/C polymorphism on renin-angiotensin-aldosterone system activity and blood pressure response to hydrochlorothiazide]. Li Y; Yang P; Wu SL; Yuan JX; Wu Y; Zhao DD; Xu S; Zhao LP; Sun MJ; Chu LM; Lu DS Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):68-71. PubMed ID: 22311496 [TBL] [Abstract][Full Text] [Related]
12. The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog. Atkins CE; Rausch WP; Gardner SY; Defrancesco TC; Keene BW; Levine JF J Vet Pharmacol Ther; 2007 Oct; 30(5):394-400. PubMed ID: 17803730 [TBL] [Abstract][Full Text] [Related]
13. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system. Biollaz J; Schelling JL; Jacot Des Combes B; Brunner DB; Desponds G; Brunner HR; Ulm EH; Hichens M; Gomez HJ Br J Clin Pharmacol; 1982 Sep; 14(3):363-8. PubMed ID: 6289859 [TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin-aldosterone complex. Melby JC Am J Med; 1986 Oct; 81(4C):8-12. PubMed ID: 3022585 [TBL] [Abstract][Full Text] [Related]
15. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects. Ohman KP; Karlberg BE Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325 [TBL] [Abstract][Full Text] [Related]
16. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019 [TBL] [Abstract][Full Text] [Related]
17. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension. Bauer IH; Reams GP; Wu Z; Lau-Sieckman A J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905 [TBL] [Abstract][Full Text] [Related]
18. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension. Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326 [TBL] [Abstract][Full Text] [Related]
19. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
20. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor. Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]